b)

Angivelserne, der svarer til indeksnumrene 006-035-00-8, 029-002-00-X, 602-020-00-0, 602-033-00-1, 603-055-00-4, 604-030-00-0, 604-092-00-9, 605-013-00-0, 605-022-00-X, 606-014-00-9, 606-021-00-7, 607-056-00-0, 607-059-00-7, 607-157-00-X, 607-172-00-1, 607-375-00-5, 607-623-00-2, 613-166-00-X, 613-121-00-4, 616-011-00-4, 616-037-00-6 og 616-207-00-X, erstattes af følgende angivelser: Indeksnr. International kemisk identifikation EF nr. CAS nr. Klassificering Mærkning Specifikke koncentrationsgrænser, M-faktorer Noter Fareklasse- og kategorikode(r) Faresætningskode(r) Piktogram-, signalordskode(r) Faresætningskode(r) Suppl. faresætningskode(r) »006-035-00-8 pirimicarb (ISO); 2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamat 245-430-1 23103-98-2 Carc. 2 Acute Tox. 3 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H331 H301 H317 H400 H410 GHS08 GHS06 GHS09 Dgr H351 H331 H301 H317 H410 M = 10 M = 100« »029-002-00-X dikobberoxid; kobber(I)oxid 215-270-7 1317-39-1 Acute Tox. 4 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H332 H302 H318 H400 H410 GHS07 GHS05 GHS09 Dgr H332 H302 H318 H410 M = 100« »602-020-00-0 1,2-dichlorpropan; propylendichlorid 201-152-2 78-87-5 Flam. Liq. 2 Carc. 1B Acute Tox. 4* Acute Tox. 4* H225 H350 H332 H302 GHS02 GHS08 GHS07 Dgr H225 H350 H332 H302« »602-033-00-1 chlorbenzen 203-628-5 108-90-7 Flam. Liq. 3 Acute Tox. 4 Skin Irrit. 2 Aquatic Chronic 2 H226 H332 H315 H411 GHS02 GHS07 GHS09 Wng H226 H332 H315 H411« »603-055-00-4 propylenoxid; 1,2-epoxypropan; methyloxiran 200-879-2 75-56-9 Flam. Liq. 1 Carc. 1B Muta. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Irrit. 2 H224 H350 H340 H331 H311 H302 H335 H319 GHS02 GHS08 GHS06 Dgr H224 H350 H340 H331 H311 H302 H335 H319« »604-030-00-0 bisphenol A; 4,4′-isopropylidendiphenol 201-245-8 80-05-7 Repr. 1B STOT SE 3 Eye Dam. 1 Skin Sens. 1 H360F H335 H318 H317 GHS08 GHS05 GHS07 Dgr H360F H335 H318 H317« »604-092-00-9 phenol, dodecyl-, forgrenet; [1] phenol, 2-dodecyl-, forgrenet; [2] phenol, 3-dodecyl-, forgrenet; [3] phenol, 4-dodecyl-, forgrenet; [4] phenol, (tetrapropenyl) derivater [5] 310-154-3 [1] [2] [3] [4] [5] 121158-58-5 [1] [2] [3] 210555-94-5 [4] 74499-35-7 [5] Repr. 1B Skin Corr. 1C Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H360F H314 H318 H400 H410 GHS08 GHS05 GHS09 Dgr H360F H314 H410 M = 10 M = 10« »605-013-00-0 chloralose (INN); (R)-1,2-O-(2,2,2-trichlorethyliden)-α-D-glucofuranose; glucochloralose; anhydroglucochloral 240-016-7 15879-93-3 Acute Tox. 4* Acute Tox. 3 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H332 H301 H336 H400 H410 GHS06 GHS09 Dgr H332 H301 H336 H410 M = 10 M = 10 C« »605-022-00-X glutaral; glutaraldehyd; 1,5-pentandial 203-856-5 111-30-8 Acute Tox. 2 Acute Tox. 3 STOT SE 3 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 2 H330 H301 H335 H314 H334 H317 H400 H411 GHS06 GHS05 GHS08 GHS09 Dgr H330 H301 H335 H314 H334 H317 H410 EUH071 STOT SE 3; H335: 0,5 % ≤ C < 5 % M = 1« »606-014-00-9 chlorphacinon (ISO); 2-[(4-chlorphenyl)(phenyl)acetyl]-1H-inden-1,3(2H)-dion 223-003-0 3691-35-8 Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (blod) H400 H410 GHS08 GHS06 GHS09 Dgr H360D H330 H310 H300 H372 (blod) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (blod): C ≥ 0,1 % STOT RE 2; H373 (blod): 0,01 % ≤ C < 0,1 % M = 1 M = 1« »606-021-00-7 N-methyl-2-pyrrolidon; 1-methyl-2-pyrrolidon 212-828-1 872-50-4 Repr. 1B STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 H360D*** H335 H315 H319 GHS08 GHS07 Dgr H360D*** H335 H315 H319 STOT SE 3; H335: C ≥ 10 %« »607-056-00-0 warfarin (ISO); 4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-on; [1] (S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyron; [2] (R)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyron [3] 201-377-6 [1] 226-907-3 [2] 226-908-9 [3] 81-81-2 [1] 5543-57-7 [2] 5543-58-8 [3] Repr. 1A Acute Tox. 1 Acute Tox. 1 Acute Tox. 2 STOT RE 1 Aquatic Chronic 2 H360D H330 H310 H300 H372 (blod) H411 GHS08 GHS06 GHS09 Dgr H360D H330 H310 H300 H372 (blod) H411 Repr. 1A; H360D: C ≥ 0,003 % STOT RE 1; H372 (blod): C ≥ 0,5 % STOT RE 2; H373 (blod): 0,05 % ≤ C < 0,5 %« »607-059-00-7 coumatetralyl (ISO); 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin 227-424-0 5836-29-3 Repr. 1B Acute Tox. 2 Acute Tox. 3 Acute Tox. 2 STOT RE 1 Aquatic Chronic 1 H360D H330 H311 H300 H372 (blod) H410 GHS08 GHS06 GHS09 Dgr H360D H330 H311 H300 H372 (blod) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (blod): C ≥ 1,0 % STOT RE 2; H373 (blod) 0,1 % ≤ C < 1,0 % M = 10« »607-157-00-X difenacoum (ISO); 3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin 259-978-4 56073-07-5 Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (blod) H400 H410 GHS08 GHS06 GHS09 Dgr H360D H330 H310 H300 H372 (blod) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (blod): C ≥ 0,02 % STOT RE 2; H373 (blod): 0,002 % ≤ C < 0,02 % M = 10 M = 10« »607-172-00-1 brodifacoum (ISO); 4-hydroxy-3-(3-(4′-brom-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin 259-980-5 56073-10-0 Repr. 1A Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (blod) H400 H410 GHS08 GHS06 GHS09 Dgr H360D H330 H310 H300 H372 (blod) H410 Repr. 1A; H360D: C ≥ 0,003 % STOT RE 1; H372 (blod): C ≥ 0,02 % STOT RE 2; H373 (blod): 0,002 % ≤ C < 0,02 % M = 10 M = 10« »607-375-00-5 flocoumafen (ISO); reaktionsblanding af: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluormethylbenzyloxy)phenyl)-1-naphthyl)coumarin og trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluormethylbenzyloxy)phenyl)-1-naphthyl)coumarin 421-960-0 90035-08-8 Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (blod) H400 H410 GHS08 GHS06 GHS09 Dgr H360D H330 H310 H300 H372 (blod) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (blod): C ≥ 0,05 % STOT RE 2; H373 (blod): 0,005 % ≤ C < 0,05 % M = 10 M = 10« »607-623-00-2 diisobutylphthalat 201-553-2 84-69-5 Repr. 1B H360Df GHS08 Dgr H360Df« »613-166-00-X flumioxazin (ISO); 2-[7-fluor-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindol-1,3(2H)-dion — 103361-09-7 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360D H400 H410 GHS08 GHS09 Dgr H360D H410 M = 1 000 M = 1 000 « »613-121-00-4 chlorsulfuron (ISO); 2-chlor-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2- yl)amino]carbonyl]benzensulphonamid 265-268-5 64902-72-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 1 000 M = 100« »616-011-00-4 N,N-dimethylacetamid 204-826-4 127-19-5 Repr. 1B Acute Tox. 4* Acute Tox. 4* H360D*** H332 H312 GHS08 GHS07 Dgr H360D*** H332 H312« »616-037-00-6 acetochlor (ISO); 2-chlor-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamid 251-899-3 34256-82-1 Carc. 2 Repr. 2 Acute Tox. 4 STOT SE 3 STOT RE 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H361f H332 H335 H373 (nyre) H315 H317 H400 H410 GHS08 GHS07 GHS09 Wng H351 H361f H332 H335 H373 (nyre) H315 H317 H410 M = 1 000 M = 100« »616-207-00-X polyhexamethylenbiguanid-hydrochlorid PHMB — 32289-58-0 27083-27-8 Carc. 2 Acute Tox. 2 Acute Tox. 4 STOT RE 1 Eye Dam. 1 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 H351 H330 H302 H372 (luftveje) (inhalation) H318 H317 H400 H410 GHS08 GHS06 GHS05 GHS09 Dgr H351 H330 H302 H372 (luftveje) (inhalation) H318 H317 H410 M = 10 M = 10«